nodes	percent_of_prediction	percent_of_DWPC	metapath
Estriol—Estropipate—osteoporosis	0.111	0.328	CrCtD
Estriol—Conjugated Estrogens—osteoporosis	0.084	0.249	CrCtD
Estriol—Estradiol—osteoporosis	0.0723	0.214	CrCtD
Estriol—Ethinyl Estradiol—osteoporosis	0.0706	0.209	CrCtD
Estriol—ESR2—osteoporosis	0.0694	0.396	CbGaD
Estriol—SHBG—osteoporosis	0.0633	0.361	CbGaD
Estriol—ESR1—osteoporosis	0.0427	0.244	CbGaD
Estriol—ESR2—Estropipate—osteoporosis	0.031	0.149	CbGbCtD
Estriol—SHBG—Estropipate—osteoporosis	0.022	0.105	CbGbCtD
Estriol—ESR2—Raloxifene—osteoporosis	0.0207	0.0993	CbGbCtD
Estriol—ESR2—Ethinyl Estradiol—osteoporosis	0.02	0.0959	CbGbCtD
Estriol—ESR1—Estropipate—osteoporosis	0.0159	0.0762	CbGbCtD
Estriol—ESR2—Conjugated Estrogens—osteoporosis	0.0147	0.0704	CbGbCtD
Estriol—SHBG—Ethinyl Estradiol—osteoporosis	0.0142	0.0679	CbGbCtD
Estriol—Equilin—Estropipate—osteoporosis	0.0141	0.0637	CrCrCtD
Estriol—ESR2—Estradiol—osteoporosis	0.0129	0.0618	CbGbCtD
Estriol—Estramustine—Estropipate—osteoporosis	0.0115	0.0521	CrCrCtD
Estriol—Equilin—Conjugated Estrogens—osteoporosis	0.0107	0.0483	CrCrCtD
Estriol—ESR1—Raloxifene—osteoporosis	0.0106	0.0508	CbGbCtD
Estriol—ESR1—Ethinyl Estradiol—osteoporosis	0.0102	0.0491	CbGbCtD
Estriol—Conjugated Estrogens—Estropipate—osteoporosis	0.00982	0.0444	CrCrCtD
Estriol—Equilin—Estradiol—osteoporosis	0.0092	0.0416	CrCrCtD
Estriol—SHBG—Estradiol—osteoporosis	0.00912	0.0438	CbGbCtD
Estriol—Equilin—Ethinyl Estradiol—osteoporosis	0.00898	0.0406	CrCrCtD
Estriol—Estramustine—Conjugated Estrogens—osteoporosis	0.00874	0.0395	CrCrCtD
Estriol—Estramustine—Estradiol—osteoporosis	0.00752	0.034	CrCrCtD
Estriol—ESR1—Conjugated Estrogens—osteoporosis	0.00751	0.036	CbGbCtD
Estriol—Estropipate—Conjugated Estrogens—osteoporosis	0.00744	0.0336	CrCrCtD
Estriol—Estramustine—Ethinyl Estradiol—osteoporosis	0.00734	0.0332	CrCrCtD
Estriol—Quinestrol—Estropipate—osteoporosis	0.00728	0.0329	CrCrCtD
Estriol—Estradiol—Estropipate—osteoporosis	0.00728	0.0329	CrCrCtD
Estriol—Mestranol—Estropipate—osteoporosis	0.00728	0.0329	CrCrCtD
Estriol—Estrone—Estropipate—osteoporosis	0.00728	0.0329	CrCrCtD
Estriol—Ethinyl Estradiol—Estropipate—osteoporosis	0.00693	0.0313	CrCrCtD
Estriol—ESR1—Estradiol—osteoporosis	0.00659	0.0316	CbGbCtD
Estriol—Conjugated Estrogens—Estradiol—osteoporosis	0.00641	0.0289	CrCrCtD
Estriol—Estropipate—Estradiol—osteoporosis	0.00641	0.0289	CrCrCtD
Estriol—Estropipate—Ethinyl Estradiol—osteoporosis	0.00625	0.0282	CrCrCtD
Estriol—Conjugated Estrogens—Ethinyl Estradiol—osteoporosis	0.00625	0.0282	CrCrCtD
Estriol—Estradiol—Conjugated Estrogens—osteoporosis	0.00552	0.0249	CrCrCtD
Estriol—Quinestrol—Conjugated Estrogens—osteoporosis	0.00552	0.0249	CrCrCtD
Estriol—Estrone—Conjugated Estrogens—osteoporosis	0.00552	0.0249	CrCrCtD
Estriol—Mestranol—Conjugated Estrogens—osteoporosis	0.00552	0.0249	CrCrCtD
Estriol—Ethinyl Estradiol—Conjugated Estrogens—osteoporosis	0.00525	0.0237	CrCrCtD
Estriol—SLCO1A2—Conjugated Estrogens—osteoporosis	0.00476	0.0229	CbGbCtD
Estriol—Quinestrol—Estradiol—osteoporosis	0.00475	0.0214	CrCrCtD
Estriol—Estrone—Estradiol—osteoporosis	0.00475	0.0214	CrCrCtD
Estriol—Mestranol—Estradiol—osteoporosis	0.00475	0.0214	CrCrCtD
Estriol—Estrone—Ethinyl Estradiol—osteoporosis	0.00463	0.0209	CrCrCtD
Estriol—Estradiol—Ethinyl Estradiol—osteoporosis	0.00463	0.0209	CrCrCtD
Estriol—Mestranol—Ethinyl Estradiol—osteoporosis	0.00463	0.0209	CrCrCtD
Estriol—Quinestrol—Ethinyl Estradiol—osteoporosis	0.00463	0.0209	CrCrCtD
Estriol—Ethinyl Estradiol—Estradiol—osteoporosis	0.00452	0.0204	CrCrCtD
Estriol—SLCO1A2—Estradiol—osteoporosis	0.00418	0.0201	CbGbCtD
Estriol—ABCB1—Ethinyl Estradiol—osteoporosis	0.00175	0.00842	CbGbCtD
Estriol—ABCB1—Conjugated Estrogens—osteoporosis	0.00129	0.00618	CbGbCtD
Estriol—ABCB1—Estradiol—osteoporosis	0.00113	0.00542	CbGbCtD
Estriol—Conjugated Estrogens—SLC51A—osteoporosis	0.000211	0.136	CrCbGaD
Estriol—Equilin—SHBG—osteoporosis	0.000181	0.116	CrCbGaD
Estriol—ABCB1—Drug Induction of Bile Acid Pathway—SLC51A—osteoporosis	0.000174	0.0897	CbGpPWpGaD
Estriol—Quinestrol—ESR1—osteoporosis	0.000116	0.0746	CrCbGaD
Estriol—Estramustine—ESR2—osteoporosis	0.000115	0.0744	CrCbGaD
Estriol—Estropipate—ESR2—osteoporosis	9.49e-05	0.0612	CrCbGaD
Estriol—Mestranol—ESR1—osteoporosis	8.77e-05	0.0565	CrCbGaD
Estriol—Estropipate—SHBG—osteoporosis	8.66e-05	0.0558	CrCbGaD
Estriol—ESR1—Signaling events mediated by HDAC Class II—TUBA1B—osteoporosis	8.45e-05	0.0435	CbGpPWpGaD
Estriol—SLCO1A2—Bile acid and bile salt metabolism—CYP27A1—osteoporosis	7.77e-05	0.04	CbGpPWpGaD
Estriol—ESR2—Ovarian Infertility Genes—CYP19A1—osteoporosis	7.19e-05	0.037	CbGpPWpGaD
Estriol—Estramustine—ESR1—osteoporosis	7.11e-05	0.0459	CrCbGaD
Estriol—Ethinyl Estradiol—ESR2—osteoporosis	6.78e-05	0.0437	CrCbGaD
Estriol—ESR2—Ovarian Infertility Genes—VDR—osteoporosis	6.29e-05	0.0324	CbGpPWpGaD
Estriol—Ethinyl Estradiol—SHBG—osteoporosis	6.19e-05	0.0399	CrCbGaD
Estriol—Conjugated Estrogens—ESR2—osteoporosis	5.93e-05	0.0382	CrCbGaD
Estriol—Estrone—ESR2—osteoporosis	5.91e-05	0.0381	CrCbGaD
Estriol—Estropipate—ESR1—osteoporosis	5.85e-05	0.0377	CrCbGaD
Estriol—ESR2—Nuclear Receptors—VDR—osteoporosis	5.48e-05	0.0282	CbGpPWpGaD
Estriol—Estrone—SHBG—osteoporosis	5.39e-05	0.0348	CrCbGaD
Estriol—Estradiol—ESR2—osteoporosis	4.48e-05	0.0289	CrCbGaD
Estriol—ESR2—Nuclear Receptor transcription pathway—VDR—osteoporosis	4.33e-05	0.0223	CbGpPWpGaD
Estriol—ESR2—Nuclear Receptors—ESR1—osteoporosis	4.19e-05	0.0216	CbGpPWpGaD
Estriol—Ethinyl Estradiol—ESR1—osteoporosis	4.18e-05	0.0269	CrCbGaD
Estriol—Estradiol—SHBG—osteoporosis	4.08e-05	0.0263	CrCbGaD
Estriol—ESR2—Plasma membrane estrogen receptor signaling—ESR1—osteoporosis	3.94e-05	0.0203	CbGpPWpGaD
Estriol—Conjugated Estrogens—ESR1—osteoporosis	3.65e-05	0.0235	CrCbGaD
Estriol—Estrone—ESR1—osteoporosis	3.64e-05	0.0235	CrCbGaD
Estriol—ABCB1—HIF-1-alpha transcription factor network—PKM—osteoporosis	3.56e-05	0.0184	CbGpPWpGaD
Estriol—ESR1—Nuclear Receptors—ESR2—osteoporosis	3.48e-05	0.0179	CbGpPWpGaD
Estriol—ESR2—Plasma membrane estrogen receptor signaling—IGF1—osteoporosis	3.41e-05	0.0176	CbGpPWpGaD
Estriol—ESR2—Nuclear Receptor transcription pathway—ESR1—osteoporosis	3.31e-05	0.017	CbGpPWpGaD
Estriol—ESR1—Plasma membrane estrogen receptor signaling—ESR2—osteoporosis	3.28e-05	0.0169	CbGpPWpGaD
Estriol—Weight increased—Estradiol—osteoporosis	3.23e-05	0.000599	CcSEcCtD
Estriol—Mental disorder—Zoledronate—osteoporosis	3.23e-05	0.000599	CcSEcCtD
Estriol—ESR2—SIDS Susceptibility Pathways—GAPDH—osteoporosis	3.22e-05	0.0166	CbGpPWpGaD
Estriol—Dyspepsia—Ibandronate—osteoporosis	3.22e-05	0.000598	CcSEcCtD
Estriol—Angiopathy—Conjugated Estrogens—osteoporosis	3.22e-05	0.000597	CcSEcCtD
Estriol—Anxiety—Ethinyl Estradiol—osteoporosis	3.21e-05	0.000597	CcSEcCtD
Estriol—Pain—Alendronate—osteoporosis	3.21e-05	0.000596	CcSEcCtD
Estriol—Weight decreased—Estradiol—osteoporosis	3.21e-05	0.000596	CcSEcCtD
Estriol—Angioedema—Pamidronate—osteoporosis	3.21e-05	0.000595	CcSEcCtD
Estriol—Malnutrition—Zoledronate—osteoporosis	3.21e-05	0.000595	CcSEcCtD
Estriol—Immune system disorder—Conjugated Estrogens—osteoporosis	3.2e-05	0.000595	CcSEcCtD
Estriol—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—osteoporosis	3.2e-05	0.000594	CcSEcCtD
Estriol—Gastrointestinal disorder—Raloxifene—osteoporosis	3.19e-05	0.000592	CcSEcCtD
Estriol—Hypertension—Risedronate—osteoporosis	3.19e-05	0.000592	CcSEcCtD
Estriol—Infestation NOS—Estradiol—osteoporosis	3.16e-05	0.000587	CcSEcCtD
Estriol—Infestation—Estradiol—osteoporosis	3.16e-05	0.000587	CcSEcCtD
Estriol—Pain—Raloxifene—osteoporosis	3.16e-05	0.000586	CcSEcCtD
Estriol—Gastrointestinal disorder—Ibandronate—osteoporosis	3.16e-05	0.000586	CcSEcCtD
Estriol—Depression—Estradiol—osteoporosis	3.15e-05	0.000585	CcSEcCtD
Estriol—Alopecia—Conjugated Estrogens—osteoporosis	3.13e-05	0.000582	CcSEcCtD
Estriol—Anxiety—Risedronate—osteoporosis	3.13e-05	0.000582	CcSEcCtD
Estriol—Pain—Ibandronate—osteoporosis	3.13e-05	0.000581	CcSEcCtD
Estriol—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	3.12e-05	0.00058	CcSEcCtD
Estriol—Pruritus—Etidronic acid—osteoporosis	3.12e-05	0.000579	CcSEcCtD
Estriol—Gastrointestinal pain—Estropipate—osteoporosis	3.12e-05	0.000579	CcSEcCtD
Estriol—Acute coronary syndrome—Estradiol—osteoporosis	3.12e-05	0.000579	CcSEcCtD
Estriol—Mental disorder—Conjugated Estrogens—osteoporosis	3.11e-05	0.000577	CcSEcCtD
Estriol—Back pain—Zoledronate—osteoporosis	3.1e-05	0.000576	CcSEcCtD
Estriol—Myocardial infarction—Estradiol—osteoporosis	3.1e-05	0.000575	CcSEcCtD
Estriol—Oedema—Ethinyl Estradiol—osteoporosis	3.09e-05	0.000574	CcSEcCtD
Estriol—Malnutrition—Conjugated Estrogens—osteoporosis	3.09e-05	0.000573	CcSEcCtD
Estriol—Muscle spasms—Zoledronate—osteoporosis	3.08e-05	0.000572	CcSEcCtD
Estriol—ESR1—AP-1 transcription factor network—COL1A2—osteoporosis	3.08e-05	0.0159	CbGpPWpGaD
Estriol—Gastrointestinal pain—Alendronate—osteoporosis	3.07e-05	0.00057	CcSEcCtD
Estriol—Infection—Ethinyl Estradiol—osteoporosis	3.07e-05	0.00057	CcSEcCtD
Estriol—Pain—Calcitriol—osteoporosis	3.06e-05	0.000568	CcSEcCtD
Estriol—Flatulence—Conjugated Estrogens—osteoporosis	3.04e-05	0.000565	CcSEcCtD
Estriol—Nervous system disorder—Ethinyl Estradiol—osteoporosis	3.03e-05	0.000563	CcSEcCtD
Estriol—Hypertension—Pamidronate—osteoporosis	3.03e-05	0.000563	CcSEcCtD
Estriol—Tension—Conjugated Estrogens—osteoporosis	3.03e-05	0.000562	CcSEcCtD
Estriol—Urticaria—Estropipate—osteoporosis	3.03e-05	0.000562	CcSEcCtD
Estriol—Gastrointestinal pain—Raloxifene—osteoporosis	3.02e-05	0.000561	CcSEcCtD
Estriol—Diarrhoea—Etidronic acid—osteoporosis	3.02e-05	0.00056	CcSEcCtD
Estriol—Abdominal pain—Estropipate—osteoporosis	3.01e-05	0.00056	CcSEcCtD
Estriol—Skin disorder—Ethinyl Estradiol—osteoporosis	3e-05	0.000557	CcSEcCtD
Estriol—Nervousness—Conjugated Estrogens—osteoporosis	3e-05	0.000557	CcSEcCtD
Estriol—Infection—Risedronate—osteoporosis	2.99e-05	0.000556	CcSEcCtD
Estriol—Hepatobiliary disease—Estradiol—osteoporosis	2.99e-05	0.000555	CcSEcCtD
Estriol—Gastrointestinal pain—Ibandronate—osteoporosis	2.99e-05	0.000555	CcSEcCtD
Estriol—Back pain—Conjugated Estrogens—osteoporosis	2.99e-05	0.000554	CcSEcCtD
Estriol—Urticaria—Alendronate—osteoporosis	2.98e-05	0.000554	CcSEcCtD
Estriol—Anxiety—Pamidronate—osteoporosis	2.98e-05	0.000553	CcSEcCtD
Estriol—Abdominal pain—Alendronate—osteoporosis	2.97e-05	0.000551	CcSEcCtD
Estriol—Muscle spasms—Conjugated Estrogens—osteoporosis	2.97e-05	0.000551	CcSEcCtD
Estriol—Shock—Risedronate—osteoporosis	2.96e-05	0.00055	CcSEcCtD
Estriol—Nervous system disorder—Risedronate—osteoporosis	2.95e-05	0.000549	CcSEcCtD
Estriol—Angioedema—Zoledronate—osteoporosis	2.93e-05	0.000544	CcSEcCtD
Estriol—ESR1—AP-1 transcription factor network—NFATC1—osteoporosis	2.93e-05	0.0151	CbGpPWpGaD
Estriol—Skin disorder—Risedronate—osteoporosis	2.93e-05	0.000543	CcSEcCtD
Estriol—Gastrointestinal pain—Calcitriol—osteoporosis	2.93e-05	0.000543	CcSEcCtD
Estriol—Abdominal pain—Raloxifene—osteoporosis	2.92e-05	0.000542	CcSEcCtD
Estriol—Urticaria—Ibandronate—osteoporosis	2.9e-05	0.000539	CcSEcCtD
Estriol—Abdominal pain—Ibandronate—osteoporosis	2.89e-05	0.000537	CcSEcCtD
Estriol—Anaphylactic shock—Pamidronate—osteoporosis	2.86e-05	0.000532	CcSEcCtD
Estriol—Oedema—Pamidronate—osteoporosis	2.86e-05	0.000532	CcSEcCtD
Estriol—Infection—Pamidronate—osteoporosis	2.85e-05	0.000528	CcSEcCtD
Estriol—Urticaria—Calcitriol—osteoporosis	2.84e-05	0.000528	CcSEcCtD
Estriol—Abdominal pain—Calcitriol—osteoporosis	2.83e-05	0.000525	CcSEcCtD
Estriol—Angioedema—Conjugated Estrogens—osteoporosis	2.82e-05	0.000524	CcSEcCtD
Estriol—Shock—Pamidronate—osteoporosis	2.82e-05	0.000523	CcSEcCtD
Estriol—Hypersensitivity—Estropipate—osteoporosis	2.81e-05	0.000522	CcSEcCtD
Estriol—Nervous system disorder—Pamidronate—osteoporosis	2.81e-05	0.000522	CcSEcCtD
Estriol—Vomiting—Etidronic acid—osteoporosis	2.8e-05	0.00052	CcSEcCtD
Estriol—Oedema peripheral—Estradiol—osteoporosis	2.8e-05	0.000519	CcSEcCtD
Estriol—Connective tissue disorder—Estradiol—osteoporosis	2.79e-05	0.000518	CcSEcCtD
Estriol—ABCB1—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	2.78e-05	0.0143	CbGpPWpGaD
Estriol—Rash—Etidronic acid—osteoporosis	2.78e-05	0.000516	CcSEcCtD
Estriol—Dermatitis—Etidronic acid—osteoporosis	2.78e-05	0.000515	CcSEcCtD
Estriol—Hypertension—Zoledronate—osteoporosis	2.77e-05	0.000514	CcSEcCtD
Estriol—Hypersensitivity—Alendronate—osteoporosis	2.77e-05	0.000514	CcSEcCtD
Estriol—ESR1—Nuclear Receptors—VDR—osteoporosis	2.76e-05	0.0142	CbGpPWpGaD
Estriol—Headache—Etidronic acid—osteoporosis	2.76e-05	0.000513	CcSEcCtD
Estriol—ESR2—Validated nuclear estrogen receptor alpha network—ESR1—osteoporosis	2.76e-05	0.0142	CbGpPWpGaD
Estriol—Estradiol—ESR1—osteoporosis	2.76e-05	0.0178	CrCbGaD
Estriol—ESR1—Nuclear Receptor transcription pathway—ESR2—osteoporosis	2.75e-05	0.0142	CbGpPWpGaD
Estriol—ESR1—Regulation of nuclear SMAD2/3 signaling—COL1A2—osteoporosis	2.74e-05	0.0141	CbGpPWpGaD
Estriol—Visual impairment—Estradiol—osteoporosis	2.73e-05	0.000508	CcSEcCtD
Estriol—Insomnia—Risedronate—osteoporosis	2.72e-05	0.000506	CcSEcCtD
Estriol—Anxiety—Zoledronate—osteoporosis	2.72e-05	0.000505	CcSEcCtD
Estriol—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	2.71e-05	0.000503	CcSEcCtD
Estriol—Pruritus—Estropipate—osteoporosis	2.7e-05	0.000501	CcSEcCtD
Estriol—Hypersensitivity—Ibandronate—osteoporosis	2.69e-05	0.0005	CcSEcCtD
Estriol—Erythema multiforme—Estradiol—osteoporosis	2.68e-05	0.000498	CcSEcCtD
Estriol—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	2.67e-05	0.000495	CcSEcCtD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	2.67e-05	0.0137	CbGpPWpGaD
Estriol—Pruritus—Alendronate—osteoporosis	2.66e-05	0.000493	CcSEcCtD
Estriol—Dyspepsia—Risedronate—osteoporosis	2.65e-05	0.000492	CcSEcCtD
Estriol—Eye disorder—Estradiol—osteoporosis	2.65e-05	0.000492	CcSEcCtD
Estriol—Hypersensitivity—Calcitriol—osteoporosis	2.64e-05	0.00049	CcSEcCtD
Estriol—Cardiac disorder—Estradiol—osteoporosis	2.63e-05	0.000489	CcSEcCtD
Estriol—Anxiety—Conjugated Estrogens—osteoporosis	2.62e-05	0.000486	CcSEcCtD
Estriol—Nausea—Etidronic acid—osteoporosis	2.62e-05	0.000486	CcSEcCtD
Estriol—Oedema—Zoledronate—osteoporosis	2.62e-05	0.000486	CcSEcCtD
Estriol—Anaphylactic shock—Zoledronate—osteoporosis	2.62e-05	0.000486	CcSEcCtD
Estriol—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	2.61e-05	0.000485	CcSEcCtD
Estriol—Diarrhoea—Estropipate—osteoporosis	2.61e-05	0.000484	CcSEcCtD
Estriol—Gastrointestinal disorder—Risedronate—osteoporosis	2.6e-05	0.000483	CcSEcCtD
Estriol—Infection—Zoledronate—osteoporosis	2.6e-05	0.000483	CcSEcCtD
Estriol—Insomnia—Pamidronate—osteoporosis	2.59e-05	0.000481	CcSEcCtD
Estriol—Pruritus—Ibandronate—osteoporosis	2.59e-05	0.00048	CcSEcCtD
Estriol—Pain—Risedronate—osteoporosis	2.58e-05	0.000478	CcSEcCtD
Estriol—Angiopathy—Estradiol—osteoporosis	2.57e-05	0.000478	CcSEcCtD
Estriol—Shock—Zoledronate—osteoporosis	2.57e-05	0.000478	CcSEcCtD
Estriol—Diarrhoea—Alendronate—osteoporosis	2.57e-05	0.000477	CcSEcCtD
Estriol—Nervous system disorder—Zoledronate—osteoporosis	2.57e-05	0.000476	CcSEcCtD
Estriol—Immune system disorder—Estradiol—osteoporosis	2.56e-05	0.000476	CcSEcCtD
Estriol—Skin disorder—Zoledronate—osteoporosis	2.54e-05	0.000472	CcSEcCtD
Estriol—Pruritus—Calcitriol—osteoporosis	2.53e-05	0.00047	CcSEcCtD
Estriol—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	2.53e-05	0.000469	CcSEcCtD
Estriol—Diarrhoea—Raloxifene—osteoporosis	2.53e-05	0.000469	CcSEcCtD
Estriol—Dyspepsia—Pamidronate—osteoporosis	2.52e-05	0.000468	CcSEcCtD
Estriol—Dizziness—Estropipate—osteoporosis	2.52e-05	0.000468	CcSEcCtD
Estriol—Oedema—Conjugated Estrogens—osteoporosis	2.52e-05	0.000468	CcSEcCtD
Estriol—Anaphylactic shock—Conjugated Estrogens—osteoporosis	2.52e-05	0.000468	CcSEcCtD
Estriol—Alopecia—Estradiol—osteoporosis	2.51e-05	0.000466	CcSEcCtD
Estriol—Infection—Conjugated Estrogens—osteoporosis	2.5e-05	0.000465	CcSEcCtD
Estriol—Diarrhoea—Ibandronate—osteoporosis	2.5e-05	0.000464	CcSEcCtD
Estriol—ABCB1—Allograft Rejection—TUBA1B—osteoporosis	2.49e-05	0.0128	CbGpPWpGaD
Estriol—Mental disorder—Estradiol—osteoporosis	2.49e-05	0.000462	CcSEcCtD
Estriol—Dizziness—Alendronate—osteoporosis	2.48e-05	0.000461	CcSEcCtD
Estriol—Shock—Conjugated Estrogens—osteoporosis	2.48e-05	0.00046	CcSEcCtD
Estriol—Gastrointestinal disorder—Pamidronate—osteoporosis	2.47e-05	0.000459	CcSEcCtD
Estriol—Nervous system disorder—Conjugated Estrogens—osteoporosis	2.47e-05	0.000459	CcSEcCtD
Estriol—Malnutrition—Estradiol—osteoporosis	2.47e-05	0.000459	CcSEcCtD
Estriol—Gastrointestinal pain—Risedronate—osteoporosis	2.46e-05	0.000457	CcSEcCtD
Estriol—Urticaria—Ethinyl Estradiol—osteoporosis	2.45e-05	0.000456	CcSEcCtD
Estriol—Pain—Pamidronate—osteoporosis	2.45e-05	0.000455	CcSEcCtD
Estriol—Diarrhoea—Calcitriol—osteoporosis	2.45e-05	0.000455	CcSEcCtD
Estriol—Skin disorder—Conjugated Estrogens—osteoporosis	2.45e-05	0.000454	CcSEcCtD
Estriol—Abdominal pain—Ethinyl Estradiol—osteoporosis	2.44e-05	0.000454	CcSEcCtD
Estriol—Dizziness—Raloxifene—osteoporosis	2.44e-05	0.000453	CcSEcCtD
Estriol—Flatulence—Estradiol—osteoporosis	2.43e-05	0.000452	CcSEcCtD
Estriol—Tension—Estradiol—osteoporosis	2.42e-05	0.00045	CcSEcCtD
Estriol—Vomiting—Estropipate—osteoporosis	2.42e-05	0.00045	CcSEcCtD
Estriol—Dizziness—Ibandronate—osteoporosis	2.42e-05	0.000449	CcSEcCtD
Estriol—Rash—Estropipate—osteoporosis	2.4e-05	0.000446	CcSEcCtD
Estriol—Dermatitis—Estropipate—osteoporosis	2.4e-05	0.000446	CcSEcCtD
Estriol—Nervousness—Estradiol—osteoporosis	2.4e-05	0.000446	CcSEcCtD
Estriol—Urticaria—Risedronate—osteoporosis	2.39e-05	0.000444	CcSEcCtD
Estriol—Back pain—Estradiol—osteoporosis	2.39e-05	0.000444	CcSEcCtD
Estriol—Headache—Estropipate—osteoporosis	2.39e-05	0.000444	CcSEcCtD
Estriol—Vomiting—Alendronate—osteoporosis	2.39e-05	0.000443	CcSEcCtD
Estriol—Abdominal pain—Risedronate—osteoporosis	2.38e-05	0.000442	CcSEcCtD
Estriol—Muscle spasms—Estradiol—osteoporosis	2.37e-05	0.000441	CcSEcCtD
Estriol—Rash—Alendronate—osteoporosis	2.37e-05	0.00044	CcSEcCtD
Estriol—Insomnia—Zoledronate—osteoporosis	2.37e-05	0.000439	CcSEcCtD
Estriol—Dermatitis—Alendronate—osteoporosis	2.37e-05	0.000439	CcSEcCtD
Estriol—Headache—Alendronate—osteoporosis	2.35e-05	0.000437	CcSEcCtD
Estriol—Vomiting—Raloxifene—osteoporosis	2.35e-05	0.000436	CcSEcCtD
Estriol—Gastrointestinal pain—Pamidronate—osteoporosis	2.34e-05	0.000435	CcSEcCtD
Estriol—Rash—Raloxifene—osteoporosis	2.33e-05	0.000432	CcSEcCtD
Estriol—Dermatitis—Raloxifene—osteoporosis	2.33e-05	0.000432	CcSEcCtD
Estriol—Vomiting—Ibandronate—osteoporosis	2.32e-05	0.000432	CcSEcCtD
Estriol—Headache—Raloxifene—osteoporosis	2.31e-05	0.00043	CcSEcCtD
Estriol—Rash—Ibandronate—osteoporosis	2.3e-05	0.000428	CcSEcCtD
Estriol—Dermatitis—Ibandronate—osteoporosis	2.3e-05	0.000428	CcSEcCtD
Estriol—Dyspepsia—Zoledronate—osteoporosis	2.3e-05	0.000428	CcSEcCtD
Estriol—ESR1—Validated nuclear estrogen receptor alpha network—ESR2—osteoporosis	2.29e-05	0.0118	CbGpPWpGaD
Estriol—Headache—Ibandronate—osteoporosis	2.29e-05	0.000425	CcSEcCtD
Estriol—Insomnia—Conjugated Estrogens—osteoporosis	2.28e-05	0.000423	CcSEcCtD
Estriol—Hypersensitivity—Ethinyl Estradiol—osteoporosis	2.28e-05	0.000423	CcSEcCtD
Estriol—Vomiting—Calcitriol—osteoporosis	2.28e-05	0.000423	CcSEcCtD
Estriol—Nausea—Estropipate—osteoporosis	2.26e-05	0.000421	CcSEcCtD
Estriol—Abdominal pain—Pamidronate—osteoporosis	2.26e-05	0.00042	CcSEcCtD
Estriol—Gastrointestinal disorder—Zoledronate—osteoporosis	2.26e-05	0.000419	CcSEcCtD
Estriol—Angioedema—Estradiol—osteoporosis	2.26e-05	0.000419	CcSEcCtD
Estriol—Rash—Calcitriol—osteoporosis	2.26e-05	0.000419	CcSEcCtD
Estriol—Dermatitis—Calcitriol—osteoporosis	2.25e-05	0.000419	CcSEcCtD
Estriol—Headache—Calcitriol—osteoporosis	2.24e-05	0.000416	CcSEcCtD
Estriol—Pain—Zoledronate—osteoporosis	2.24e-05	0.000415	CcSEcCtD
Estriol—Nausea—Alendronate—osteoporosis	2.23e-05	0.000414	CcSEcCtD
Estriol—Hypersensitivity—Risedronate—osteoporosis	2.22e-05	0.000412	CcSEcCtD
Estriol—Dyspepsia—Conjugated Estrogens—osteoporosis	2.22e-05	0.000412	CcSEcCtD
Estriol—Nausea—Raloxifene—osteoporosis	2.19e-05	0.000407	CcSEcCtD
Estriol—Pruritus—Ethinyl Estradiol—osteoporosis	2.19e-05	0.000406	CcSEcCtD
Estriol—ESR1—Nuclear Receptor transcription pathway—VDR—osteoporosis	2.18e-05	0.0112	CbGpPWpGaD
Estriol—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	2.17e-05	0.000404	CcSEcCtD
Estriol—Nausea—Ibandronate—osteoporosis	2.17e-05	0.000403	CcSEcCtD
Estriol—Pain—Conjugated Estrogens—osteoporosis	2.15e-05	0.0004	CcSEcCtD
Estriol—Gastrointestinal pain—Zoledronate—osteoporosis	2.14e-05	0.000397	CcSEcCtD
Estriol—Hypertension—Estradiol—osteoporosis	2.13e-05	0.000396	CcSEcCtD
Estriol—Pruritus—Risedronate—osteoporosis	2.13e-05	0.000396	CcSEcCtD
Estriol—Nausea—Calcitriol—osteoporosis	2.13e-05	0.000395	CcSEcCtD
Estriol—Diarrhoea—Ethinyl Estradiol—osteoporosis	2.11e-05	0.000393	CcSEcCtD
Estriol—Hypersensitivity—Pamidronate—osteoporosis	2.11e-05	0.000392	CcSEcCtD
Estriol—Anxiety—Estradiol—osteoporosis	2.1e-05	0.000389	CcSEcCtD
Estriol—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	2.09e-05	0.000388	CcSEcCtD
Estriol—Urticaria—Zoledronate—osteoporosis	2.08e-05	0.000386	CcSEcCtD
Estriol—Abdominal pain—Zoledronate—osteoporosis	2.07e-05	0.000384	CcSEcCtD
Estriol—Diarrhoea—Risedronate—osteoporosis	2.06e-05	0.000383	CcSEcCtD
Estriol—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	2.06e-05	0.000383	CcSEcCtD
Estriol—Dizziness—Ethinyl Estradiol—osteoporosis	2.04e-05	0.000379	CcSEcCtD
Estriol—Pruritus—Pamidronate—osteoporosis	2.03e-05	0.000376	CcSEcCtD
Estriol—Oedema—Estradiol—osteoporosis	2.02e-05	0.000374	CcSEcCtD
Estriol—Anaphylactic shock—Estradiol—osteoporosis	2.02e-05	0.000374	CcSEcCtD
Estriol—Infection—Estradiol—osteoporosis	2e-05	0.000372	CcSEcCtD
Estriol—Urticaria—Conjugated Estrogens—osteoporosis	2e-05	0.000372	CcSEcCtD
Estriol—Dizziness—Risedronate—osteoporosis	1.99e-05	0.00037	CcSEcCtD
Estriol—Abdominal pain—Conjugated Estrogens—osteoporosis	1.99e-05	0.00037	CcSEcCtD
Estriol—Shock—Estradiol—osteoporosis	1.98e-05	0.000368	CcSEcCtD
Estriol—Nervous system disorder—Estradiol—osteoporosis	1.98e-05	0.000367	CcSEcCtD
Estriol—Vomiting—Ethinyl Estradiol—osteoporosis	1.96e-05	0.000365	CcSEcCtD
Estriol—Diarrhoea—Pamidronate—osteoporosis	1.96e-05	0.000364	CcSEcCtD
Estriol—Skin disorder—Estradiol—osteoporosis	1.96e-05	0.000364	CcSEcCtD
Estriol—Rash—Ethinyl Estradiol—osteoporosis	1.95e-05	0.000362	CcSEcCtD
Estriol—Dermatitis—Ethinyl Estradiol—osteoporosis	1.95e-05	0.000361	CcSEcCtD
Estriol—Headache—Ethinyl Estradiol—osteoporosis	1.94e-05	0.000359	CcSEcCtD
Estriol—Hypersensitivity—Zoledronate—osteoporosis	1.93e-05	0.000358	CcSEcCtD
Estriol—Vomiting—Risedronate—osteoporosis	1.92e-05	0.000356	CcSEcCtD
Estriol—Rash—Risedronate—osteoporosis	1.9e-05	0.000353	CcSEcCtD
Estriol—Dermatitis—Risedronate—osteoporosis	1.9e-05	0.000352	CcSEcCtD
Estriol—Dizziness—Pamidronate—osteoporosis	1.89e-05	0.000352	CcSEcCtD
Estriol—Headache—Risedronate—osteoporosis	1.89e-05	0.00035	CcSEcCtD
Estriol—Hypersensitivity—Conjugated Estrogens—osteoporosis	1.86e-05	0.000345	CcSEcCtD
Estriol—Pruritus—Zoledronate—osteoporosis	1.85e-05	0.000344	CcSEcCtD
Estriol—Nausea—Ethinyl Estradiol—osteoporosis	1.84e-05	0.000341	CcSEcCtD
Estriol—Insomnia—Estradiol—osteoporosis	1.82e-05	0.000339	CcSEcCtD
Estriol—Vomiting—Pamidronate—osteoporosis	1.82e-05	0.000338	CcSEcCtD
Estriol—Rash—Pamidronate—osteoporosis	1.81e-05	0.000335	CcSEcCtD
Estriol—Dermatitis—Pamidronate—osteoporosis	1.8e-05	0.000335	CcSEcCtD
Estriol—Headache—Pamidronate—osteoporosis	1.79e-05	0.000333	CcSEcCtD
Estriol—Diarrhoea—Zoledronate—osteoporosis	1.79e-05	0.000332	CcSEcCtD
Estriol—Nausea—Risedronate—osteoporosis	1.79e-05	0.000332	CcSEcCtD
Estriol—Pruritus—Conjugated Estrogens—osteoporosis	1.78e-05	0.000331	CcSEcCtD
Estriol—Dyspepsia—Estradiol—osteoporosis	1.77e-05	0.00033	CcSEcCtD
Estriol—Gastrointestinal disorder—Estradiol—osteoporosis	1.74e-05	0.000323	CcSEcCtD
Estriol—Dizziness—Zoledronate—osteoporosis	1.73e-05	0.000321	CcSEcCtD
Estriol—Pain—Estradiol—osteoporosis	1.72e-05	0.00032	CcSEcCtD
Estriol—Diarrhoea—Conjugated Estrogens—osteoporosis	1.72e-05	0.00032	CcSEcCtD
Estriol—ESR1—Plasma membrane estrogen receptor signaling—IGF1—osteoporosis	1.72e-05	0.00885	CbGpPWpGaD
Estriol—Nausea—Pamidronate—osteoporosis	1.7e-05	0.000316	CcSEcCtD
Estriol—Dizziness—Conjugated Estrogens—osteoporosis	1.67e-05	0.000309	CcSEcCtD
Estriol—Vomiting—Zoledronate—osteoporosis	1.66e-05	0.000309	CcSEcCtD
Estriol—Rash—Zoledronate—osteoporosis	1.65e-05	0.000306	CcSEcCtD
Estriol—Gastrointestinal pain—Estradiol—osteoporosis	1.65e-05	0.000306	CcSEcCtD
Estriol—Dermatitis—Zoledronate—osteoporosis	1.65e-05	0.000306	CcSEcCtD
Estriol—Headache—Zoledronate—osteoporosis	1.64e-05	0.000304	CcSEcCtD
Estriol—ESR1—Integrated Breast Cancer Pathway—RAP1A—osteoporosis	1.62e-05	0.00835	CbGpPWpGaD
Estriol—Vomiting—Conjugated Estrogens—osteoporosis	1.6e-05	0.000297	CcSEcCtD
Estriol—Urticaria—Estradiol—osteoporosis	1.6e-05	0.000297	CcSEcCtD
Estriol—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	1.6e-05	0.00823	CbGpPWpGaD
Estriol—Abdominal pain—Estradiol—osteoporosis	1.59e-05	0.000296	CcSEcCtD
Estriol—Rash—Conjugated Estrogens—osteoporosis	1.59e-05	0.000295	CcSEcCtD
Estriol—Dermatitis—Conjugated Estrogens—osteoporosis	1.59e-05	0.000295	CcSEcCtD
Estriol—Headache—Conjugated Estrogens—osteoporosis	1.58e-05	0.000293	CcSEcCtD
Estriol—Nausea—Zoledronate—osteoporosis	1.55e-05	0.000289	CcSEcCtD
Estriol—ESR1—Regulation of nuclear SMAD2/3 signaling—VDR—osteoporosis	1.51e-05	0.00776	CbGpPWpGaD
Estriol—Nausea—Conjugated Estrogens—osteoporosis	1.5e-05	0.000278	CcSEcCtD
Estriol—SLCO1A2—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	1.49e-05	0.00765	CbGpPWpGaD
Estriol—Hypersensitivity—Estradiol—osteoporosis	1.49e-05	0.000276	CcSEcCtD
Estriol—ESR2—Validated nuclear estrogen receptor alpha network—MYC—osteoporosis	1.44e-05	0.00739	CbGpPWpGaD
Estriol—Pruritus—Estradiol—osteoporosis	1.43e-05	0.000265	CcSEcCtD
Estriol—SLCO1A2—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	1.41e-05	0.00725	CbGpPWpGaD
Estriol—Diarrhoea—Estradiol—osteoporosis	1.38e-05	0.000256	CcSEcCtD
Estriol—ABCB1—HIF-1-alpha transcription factor network—ENO1—osteoporosis	1.35e-05	0.00693	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	1.34e-05	0.00692	CbGpPWpGaD
Estriol—Dizziness—Estradiol—osteoporosis	1.33e-05	0.000248	CcSEcCtD
Estriol—ESR1—Leptin signaling pathway—LEP—osteoporosis	1.28e-05	0.00661	CbGpPWpGaD
Estriol—Vomiting—Estradiol—osteoporosis	1.28e-05	0.000238	CcSEcCtD
Estriol—Rash—Estradiol—osteoporosis	1.27e-05	0.000236	CcSEcCtD
Estriol—Dermatitis—Estradiol—osteoporosis	1.27e-05	0.000236	CcSEcCtD
Estriol—Headache—Estradiol—osteoporosis	1.26e-05	0.000235	CcSEcCtD
Estriol—Nausea—Estradiol—osteoporosis	1.2e-05	0.000222	CcSEcCtD
Estriol—ESR2—SIDS Susceptibility Pathways—IL6R—osteoporosis	1.19e-05	0.00611	CbGpPWpGaD
Estriol—ESR2—Gene Expression—U2AF1—osteoporosis	1.18e-05	0.0061	CbGpPWpGaD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	1.15e-05	0.00592	CbGpPWpGaD
Estriol—ESR1—Leptin signaling pathway—IRS1—osteoporosis	1.15e-05	0.0059	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	1.1e-05	0.00564	CbGpPWpGaD
Estriol—ESR1—Signaling by ERBB4—KL—osteoporosis	1.09e-05	0.0056	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	1.07e-05	0.0055	CbGpPWpGaD
Estriol—ESR1—Integrated Breast Cancer Pathway—CYP19A1—osteoporosis	1.05e-05	0.0054	CbGpPWpGaD
Estriol—ESR1—FOXM1 transcription factor network—MYC—osteoporosis	1.01e-05	0.00522	CbGpPWpGaD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	9.96e-06	0.00513	CbGpPWpGaD
Estriol—ESR1—LKB1 signaling events—MYC—osteoporosis	9.95e-06	0.00512	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	9.57e-06	0.00493	CbGpPWpGaD
Estriol—ESR1—Aryl Hydrocarbon Receptor—MYC—osteoporosis	9.43e-06	0.00485	CbGpPWpGaD
Estriol—SLCO1A2—Transmembrane transport of small molecules—ANXA2—osteoporosis	9.28e-06	0.00478	CbGpPWpGaD
Estriol—ESR2—SIDS Susceptibility Pathways—IL1B—osteoporosis	9.03e-06	0.00465	CbGpPWpGaD
Estriol—ESR2—Gene Expression—RPL24—osteoporosis	8.8e-06	0.00453	CbGpPWpGaD
Estriol—ESR1—Aryl Hydrocarbon Receptor—TNF—osteoporosis	8.78e-06	0.00452	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	8.54e-06	0.00439	CbGpPWpGaD
Estriol—ESR1—Leptin signaling pathway—IL1B—osteoporosis	8.18e-06	0.00421	CbGpPWpGaD
Estriol—ABCB1—HIF-1-alpha transcription factor network—LEP—osteoporosis	7.52e-06	0.00387	CbGpPWpGaD
Estriol—ESR2—Generic Transcription Pathway—VDR—osteoporosis	7.48e-06	0.00385	CbGpPWpGaD
Estriol—ESR1—Signaling by ERBB4—IRS2—osteoporosis	7.46e-06	0.00384	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	7.26e-06	0.00374	CbGpPWpGaD
Estriol—ESR1—Validated nuclear estrogen receptor alpha network—MYC—osteoporosis	7.24e-06	0.00373	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	7.11e-06	0.00366	CbGpPWpGaD
Estriol—ESR1—Regulation of Telomerase—MYC—osteoporosis	6.9e-06	0.00355	CbGpPWpGaD
Estriol—ESR1—Regulation of Telomerase—TGFB1—osteoporosis	6.88e-06	0.00354	CbGpPWpGaD
Estriol—ESR1—AP-1 transcription factor network—MYC—osteoporosis	6.74e-06	0.00347	CbGpPWpGaD
Estriol—ESR1—AP-1 transcription factor network—TGFB1—osteoporosis	6.72e-06	0.00346	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—PKM—osteoporosis	6.62e-06	0.00341	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—FDPS—osteoporosis	6.62e-06	0.00341	CbGpPWpGaD
Estriol—ESR2—SIDS Susceptibility Pathways—TNF—osteoporosis	6.56e-06	0.00337	CbGpPWpGaD
Estriol—ESR1—Integrated Breast Cancer Pathway—IRS1—osteoporosis	6.54e-06	0.00337	CbGpPWpGaD
Estriol—ESR1—Signaling by ERBB4—IRS1—osteoporosis	6.51e-06	0.00335	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—PGLS—osteoporosis	6.27e-06	0.00323	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—GPD2—osteoporosis	6.27e-06	0.00323	CbGpPWpGaD
Estriol—ESR1—Signaling by ERBB4—IL6R—osteoporosis	6.11e-06	0.00315	CbGpPWpGaD
Estriol—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—osteoporosis	5.99e-06	0.00309	CbGpPWpGaD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	5.99e-06	0.00308	CbGpPWpGaD
Estriol—ESR1—Gene Expression—U2AF1—osteoporosis	5.97e-06	0.00307	CbGpPWpGaD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	5.97e-06	0.00307	CbGpPWpGaD
Estriol—ESR1—ATF-2 transcription factor network—IL6—osteoporosis	5.81e-06	0.00299	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—PNP—osteoporosis	5.74e-06	0.00295	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—ATIC—osteoporosis	5.74e-06	0.00295	CbGpPWpGaD
Estriol—ESR2—Generic Transcription Pathway—ESR1—osteoporosis	5.72e-06	0.00294	CbGpPWpGaD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	5.58e-06	0.00287	CbGpPWpGaD
Estriol—ESR2—SIDS Susceptibility Pathways—IL6—osteoporosis	5.29e-06	0.00272	CbGpPWpGaD
Estriol—ESR2—Gene Expression—PSMA5—osteoporosis	5.08e-06	0.00261	CbGpPWpGaD
Estriol—ESR2—Gene Expression—PSMA2—osteoporosis	5.08e-06	0.00261	CbGpPWpGaD
Estriol—ESR1—AP-1 transcription factor network—IL6—osteoporosis	5.06e-06	0.00261	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	5.06e-06	0.00261	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	5.02e-06	0.00259	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—CA2—osteoporosis	4.88e-06	0.00251	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—OXCT1—osteoporosis	4.88e-06	0.00251	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—MGLL—osteoporosis	4.75e-06	0.00245	CbGpPWpGaD
Estriol—ESR1—Generic Transcription Pathway—ESR2—osteoporosis	4.75e-06	0.00245	CbGpPWpGaD
Estriol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—osteoporosis	4.74e-06	0.00244	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	4.48e-06	0.00231	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—SOST—osteoporosis	4.48e-06	0.00231	CbGpPWpGaD
Estriol—ESR1—Gene Expression—RPL24—osteoporosis	4.44e-06	0.00228	CbGpPWpGaD
Estriol—ABCB1—Allograft Rejection—IL1B—osteoporosis	4.15e-06	0.00214	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—CALCR—osteoporosis	4.05e-06	0.00208	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—PTH1R—osteoporosis	4.05e-06	0.00208	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—IDH2—osteoporosis	4.04e-06	0.00208	CbGpPWpGaD
Estriol—ABCB1—Transmembrane transport of small molecules—ANXA2—osteoporosis	3.97e-06	0.00205	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—CYP27A1—osteoporosis	3.8e-06	0.00196	CbGpPWpGaD
Estriol—ESR1—Generic Transcription Pathway—VDR—osteoporosis	3.77e-06	0.00194	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—ACP5—osteoporosis	3.7e-06	0.0019	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	3.65e-06	0.00188	CbGpPWpGaD
Estriol—ESR1—Integrated Breast Cancer Pathway—MYC—osteoporosis	3.64e-06	0.00188	CbGpPWpGaD
Estriol—ESR2—Gene Expression—VDR—osteoporosis	3.6e-06	0.00185	CbGpPWpGaD
Estriol—SLCO1A2—Transmembrane transport of small molecules—ADCY5—osteoporosis	3.48e-06	0.00179	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—TPI1—osteoporosis	3.44e-06	0.00177	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—P4HB—osteoporosis	3.23e-06	0.00166	CbGpPWpGaD
Estriol—ABCB1—Allograft Rejection—TGFB1—osteoporosis	3.23e-06	0.00166	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—MGLL—osteoporosis	3.22e-06	0.00166	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—GAPDH—osteoporosis	3.17e-06	0.00163	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—LRP5—osteoporosis	3.14e-06	0.00162	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—RAP1A—osteoporosis	3.09e-06	0.00159	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	3.07e-06	0.00158	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	3.02e-06	0.00155	CbGpPWpGaD
Estriol—ABCB1—Allograft Rejection—TNF—osteoporosis	3.01e-06	0.00155	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	3.01e-06	0.00155	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—LRP6—osteoporosis	3e-06	0.00155	CbGpPWpGaD
Estriol—ESR2—Generic Transcription Pathway—MYC—osteoporosis	2.97e-06	0.00153	CbGpPWpGaD
Estriol—ABCB1—Metabolism—FDPS—osteoporosis	2.83e-06	0.00146	CbGpPWpGaD
Estriol—ABCB1—Metabolism—PKM—osteoporosis	2.83e-06	0.00146	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	2.81e-06	0.00145	CbGpPWpGaD
Estriol—ESR2—Gene Expression—ESR1—osteoporosis	2.75e-06	0.00142	CbGpPWpGaD
Estriol—ESR1—Signaling by ERBB4—IL6—osteoporosis	2.72e-06	0.0014	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.69e-06	0.00139	CbGpPWpGaD
Estriol—ABCB1—Metabolism—PGLS—osteoporosis	2.69e-06	0.00138	CbGpPWpGaD
Estriol—ABCB1—Metabolism—GPD2—osteoporosis	2.69e-06	0.00138	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	2.66e-06	0.00137	CbGpPWpGaD
Estriol—ESR1—Gene Expression—PSMA2—osteoporosis	2.56e-06	0.00132	CbGpPWpGaD
Estriol—ESR1—Gene Expression—PSMA5—osteoporosis	2.56e-06	0.00132	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—TLN1—osteoporosis	2.54e-06	0.00131	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—ENO1—osteoporosis	2.5e-06	0.00129	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—PSMA2—osteoporosis	2.46e-06	0.00127	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—PSMA5—osteoporosis	2.46e-06	0.00127	CbGpPWpGaD
Estriol—ABCB1—Metabolism—PNP—osteoporosis	2.46e-06	0.00126	CbGpPWpGaD
Estriol—ABCB1—Metabolism—ATIC—osteoporosis	2.46e-06	0.00126	CbGpPWpGaD
Estriol—ESR1—Gene Expression—ESR2—osteoporosis	2.29e-06	0.00118	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—P4HB—osteoporosis	2.19e-06	0.00113	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—PTH—osteoporosis	2.13e-06	0.0011	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—RAP1A—osteoporosis	2.09e-06	0.00108	CbGpPWpGaD
Estriol—ABCB1—Metabolism—OXCT1—osteoporosis	2.09e-06	0.00108	CbGpPWpGaD
Estriol—ABCB1—Metabolism—CA2—osteoporosis	2.09e-06	0.00108	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—CNR2—osteoporosis	2.07e-06	0.00107	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—NFATC1—osteoporosis	2.04e-06	0.00105	CbGpPWpGaD
Estriol—ABCB1—Metabolism—MGLL—osteoporosis	2.04e-06	0.00105	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—DKK1—osteoporosis	2.02e-06	0.00104	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—CYP19A1—osteoporosis	2e-06	0.00103	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—WNT1—osteoporosis	1.95e-06	0.001	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—FGA—osteoporosis	1.9e-06	0.000976	CbGpPWpGaD
Estriol—ESR1—Gene Expression—VDR—osteoporosis	1.82e-06	0.000935	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—PTHLH—osteoporosis	1.76e-06	0.000907	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—BMP2—osteoporosis	1.76e-06	0.000907	CbGpPWpGaD
Estriol—ABCB1—Metabolism—IDH2—osteoporosis	1.73e-06	0.000891	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—FGB—osteoporosis	1.72e-06	0.000888	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—PSMA2—osteoporosis	1.67e-06	0.000857	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—PSMA5—osteoporosis	1.67e-06	0.000857	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—ADCY5—osteoporosis	1.63e-06	0.00084	CbGpPWpGaD
Estriol—ABCB1—Metabolism—CYP27A1—osteoporosis	1.63e-06	0.000838	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—GPX1—osteoporosis	1.63e-06	0.000837	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	1.6e-06	0.000822	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	1.59e-06	0.00082	CbGpPWpGaD
Estriol—ABCB1—Metabolism—ACP5—osteoporosis	1.58e-06	0.000815	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—CALCA—osteoporosis	1.55e-06	0.000799	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—MTHFR—osteoporosis	1.5e-06	0.000772	CbGpPWpGaD
Estriol—ESR1—Generic Transcription Pathway—MYC—osteoporosis	1.5e-06	0.000772	CbGpPWpGaD
Estriol—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.49e-06	0.000768	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	1.49e-06	0.000766	CbGpPWpGaD
Estriol—ABCB1—Metabolism—TPI1—osteoporosis	1.47e-06	0.000758	CbGpPWpGaD
Estriol—ESR2—Gene Expression—MYC—osteoporosis	1.43e-06	0.000737	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—KL—osteoporosis	1.41e-06	0.000725	CbGpPWpGaD
Estriol—ABCB1—Metabolism—P4HB—osteoporosis	1.38e-06	0.000712	CbGpPWpGaD
Estriol—ABCB1—Metabolism—GAPDH—osteoporosis	1.36e-06	0.000699	CbGpPWpGaD
Estriol—ABCB1—Metabolism—RAP1A—osteoporosis	1.32e-06	0.000681	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—POMC—osteoporosis	1.2e-06	0.000618	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—ADCY5—osteoporosis	1.1e-06	0.000568	CbGpPWpGaD
Estriol—ABCB1—Metabolism—ENO1—osteoporosis	1.07e-06	0.00055	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—SPP1—osteoporosis	1.07e-06	0.00055	CbGpPWpGaD
Estriol—ABCB1—Metabolism—PSMA5—osteoporosis	1.05e-06	0.000542	CbGpPWpGaD
Estriol—ABCB1—Metabolism—PSMA2—osteoporosis	1.05e-06	0.000542	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—IRS2—osteoporosis	9.66e-07	0.000497	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—LEP—osteoporosis	9.45e-07	0.000487	CbGpPWpGaD
Estriol—ABCB1—Metabolism—CYP19A1—osteoporosis	8.55e-07	0.00044	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—IRS1—osteoporosis	8.43e-07	0.000434	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—POMC—osteoporosis	8.12e-07	0.000418	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—IL6R—osteoporosis	7.92e-07	0.000408	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—IGF1—osteoporosis	7.81e-07	0.000402	CbGpPWpGaD
Estriol—ESR1—Gene Expression—MYC—osteoporosis	7.22e-07	0.000372	CbGpPWpGaD
Estriol—ABCB1—Metabolism—ADCY5—osteoporosis	6.98e-07	0.00036	CbGpPWpGaD
Estriol—ABCB1—Metabolism—GPX1—osteoporosis	6.96e-07	0.000358	CbGpPWpGaD
Estriol—ABCB1—Metabolism—MTHFR—osteoporosis	6.42e-07	0.000331	CbGpPWpGaD
Estriol—ABCB1—Metabolism—POMC—osteoporosis	5.14e-07	0.000264	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—MYC—osteoporosis	4.69e-07	0.000242	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—TGFB1—osteoporosis	4.68e-07	0.000241	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—IL6—osteoporosis	3.53e-07	0.000182	CbGpPWpGaD
